Literature DB >> 628528

Stimulation of follicular growth with "pure" FSH in patients with anovulation and elevated LH levels.

J Schoemaker, A C Wentz, G S Jones, N H Dubin, K C Sapp.   

Abstract

Ovarian follicular growth was stimulated in 4 patients with clomiphene resistant polycystic ovary (PCO)-like disease, with "pure" human pituitary FSH during 10 cycles. In 8 cycles additional hCG was given to induce ovulation. Serum LH and FSH and plasma estradiol and progesterone were determined daily. From the response patterns of steroidogenesis, four functional stages of follicular development can be distinguished, each subsequent stage being characterized by an increasing spontaneous estradiol production and a decreasing capacity to produce extra estradiol in response to stimulation with additional hCG. It is concluded that the unpredictable response to gonadotropin stimulation of patients with PCO-like disease is due to the varying state of development of the follicles at the start of the stimulation. The suggestion is made, based on the different responses in 3 cycles of the same patient (EW), that the lack of positive estrogen feedback in patients with PCO-like disease may be a hyposensitivity to estrogens rather than an absolute insensitivity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628528     DOI: 10.1097/00006250-197803000-00003

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

Review 1.  Progress in ovulation induction with gonadotropins.

Authors:  P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1989-06

2.  Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome.

Authors:  Mika Kanaya; Tsuyoshi Baba; Yoshimitsu Kitajima; Keiko Ikeda; Ayumi Shimizu; Miyuki Morishita; Hiroyuki Honnma; Toshiaki Endo; Tsuyoshi Saito
Journal:  Int J Womens Health       Date:  2012-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.